The National Organization For Rare
Disorders Inc
CAGE Code: 062L2
NCAGE Code: 062L2
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 147831150
Summary
The National Organization For Rare, Disorders Inc is an Active Commercial Supplier with the Cage Code 062L2 and is tracked by Dun & Bradstreet under DUNS Number 147831150..
Address
1900 Crown Colony Dr
Ste 310
Quincy MA 02169-0949
United States
Points of Contact
- Telephone:
- 6179546386
- Fax:
- 6172497301
Related Information
People who viewed this 'CAGE Code' also viewed...
Deters All Star Dairy Inc Artcraft Co Oscar H Brinks Inc Bennet Ansel Associates Specialty Chemical Mfg Inc Cardinal Air Conditioning Co Inc Klingner & Associates Pc Barlow Associates A.F. Murphy Die & Machine Co Inc Cartech Inc Brite Lite Electrical Co Inc Sierra Tom Co Inc Claremont Corp E.A. Wand Plumbing & Heating Company Twomey David P R. L. Brink Corp. Hunter R F Co Inc Howell Robert And Associates Precision Marketing Inc Quincy Specialties Co Inc Martso Machine Co
Frequently Asked Questions (FAQ) for CAGE 062L2
- What is CAGE Code 062L2?
- 062L2 is the unique identifier used by NATO Organizations to reference the physical entity known as The National Organization For Rare Disorders Inc located at 1900 Crown Colony Dr, Ste 310, Quincy MA 02169-0949, United States.
- Who is CAGE Code 062L2?
- 062L2 refers to The National Organization For Rare Disorders Inc located at 1900 Crown Colony Dr, Ste 310, Quincy MA 02169-0949, United States.
- Where is CAGE Code 062L2 Located?
- CAGE Code 062L2 is located in Quincy, MA, USA.
Contracting History for CAGE 062L2 Most Recent 25 Records
- 75F40119C10091
- Modification To Extend The Period Of Performance Through 09/15/2024 And Add Funding.
- 29 Jun 2022
- Modification To Extend The Period Of Performance Through 09/15/2024 And Add Funding.
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $1,464,208.71
- Department Of Health And Human Services (Hhs)
- 75F40119C10091
- Modification To Re-Ob Funds To Fix An Ipp Issue
- 21 Sep 2023
- Modification To Re-Ob Funds To Fix An Ipp Issue
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $1,464,208.71
- Department Of Health And Human Services (Hhs)
- 75F40119C10091
- Modification To Extend The Period Of Performance Until 09/152022 For Board Agency Announcement: Fdavaa-19-00123-A3 " A Systems-Based Approach To Patient-Focused Research And Product Development"
- 17 Jun 2021
- Modification To Extend The Period Of Performance Until 09/152022 For Board Agency Announcement: Fdavaa-19-00123-A3 " A Systems-Based Approach To Patient-Focused Research And Product Development"
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $1,293,750.00
- Department Of Health And Human Services (Hhs)
- 75F40119C10091
- The Purpose Of This Modification Is To Change The Buyer For Invoicing Purposes. All Other Terms And Conditions Remain Unchanged.
- 5 Jan 2024
- The Purpose Of This Modification Is To Change The Buyer For Invoicing Purposes. All Other Terms And Conditions Remain Unchanged.
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $1,464,208.71
- Department Of Health And Human Services (Hhs)
- 75F40119C10091
- Modification To Extend The Period Of Performance Through 09/15/2024 And Add Funding.
- 9 Feb 2023
- Modification To Extend The Period Of Performance Through 09/15/2024 And Add Funding.
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $1,464,208.71
- Department Of Health And Human Services (Hhs)
- 75F40119C10091
- Modification To De-Ob Funds To Fix An Ipp Issue
- 15 May 2023
- Modification To De-Ob Funds To Fix An Ipp Issue
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $1,013,827.50
- Department Of Health And Human Services (Hhs)